Iterum Therapeutics plc (ITRMF) Other Accumulated Expenses (2017 - 2025)

Iterum Therapeutics has reported Other Accumulated Expenses for 9 years, with the latest figure at $332000.0 in Q3 2025.

• On a quarterly basis, Other Accumulated Expenses fell 50.3% year-over-year to $332000.0 in Q3 2025; TTM through Sep 2025 was $332000.0, a 50.3% decrease from a year earlier, with the FY2024 full-year figure at $365000.0, down 52.04% from the prior year.
• Other Accumulated Expenses was $332000.0 for Q3 2025 at Iterum Therapeutics, up from $197000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $4.3 million in Q2 2021, with the low at $197000.0 in Q2 2025.
• Average Other Accumulated Expenses over 5 years is $1.7 million, with a median of $1.7 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2025: Other Accumulated Expenses jumped 43.45% in 2021, then plunged 73.41% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $3.0 million in 2021, then sank by 41.58% to $1.7 million in 2022, then tumbled by 56.46% to $761000.0 in 2023, then plunged by 52.04% to $365000.0 in 2024, then dropped by 9.04% to $332000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $332000.0 (Q3 2025), $197000.0 (Q2 2025), and $201000.0 (Q1 2025), per Business Quant data.